Exercise During Pregnancy and Urinary Incontinence
Sponsor
Universidad Politecnica de Madrid (Other)
Overall Status
Unknown status
CT.gov ID
NCT03997045
Collaborator
(none)
50
1
2
17
2.9
Study Details
Study Description
Brief Summary
The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on urinary incontinence.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Prevention
Official Title:
Effect of Physical Exercise Program During Pregnancy on Urinary Incontinence
Actual Study Start Date
:
Mar 1, 2019
Anticipated Primary Completion Date
:
Jan 31, 2020
Anticipated Study Completion Date
:
Jul 30, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention group Pregnant women receiving usual care and participating in supervised physical exercise program. |
Behavioral: Supervised physical exercise program
Supervised physical conditioning program of two 60-minutes sessions per week during pregnancy, developed from gestational week 20 to 38. Each session consists of 25-30 minutes of cardiovascular exercise,15 minutes of strengthening exercises, 5 minutes of coordination and balance exercises and 10 minutes of pelvic floor muscles training.
|
No Intervention: Control group Pregnant women that are receiving usual care but are not participating in supervised physical exercise program. |
Outcome Measures
Primary Outcome Measures
- Urinary incontinence [Gestational week 36-38]
Urinary incontinence was measured by the International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF).
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Healthy pregnant women
Exclusion Criteria:
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Universidad Politécnica de Madrid | Madrid | Spain | 28040 |
Sponsors and Collaborators
- Universidad Politecnica de Madrid
Investigators
- Study Director: Ruben Barakat Carballo, PhD, Universidad Politécnica de Madrid
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Marina Vargas Terrones,
PhD,
Universidad Politecnica de Madrid
ClinicalTrials.gov Identifier:
NCT03997045
Other Study ID Numbers:
- AFIPE-001
First Posted:
Jun 25, 2019
Last Update Posted:
Jun 25, 2019
Last Verified:
Jun 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marina Vargas Terrones,
PhD,
Universidad Politecnica de Madrid
Additional relevant MeSH terms: